Detalhe da pesquisa
1.
Can HDL cholesterol be replaced by paraoxonase 1 activity in the prediction of severe coronary artery disease in patients with type 2 diabetes?
Nutr Metab Cardiovasc Dis
; 33(8): 1599-1607, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37344284
2.
Epigenetics of paraoxonases.
Curr Opin Lipidol
; 31(4): 200-205, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32487820
3.
Phenotypes and concentration of PON1 in cardiovascular disease: The role of nutrient intake.
Nutr Metab Cardiovasc Dis
; 30(1): 40-48, 2020 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31757567
4.
Coincubation of PON1, APO A1, and LCAT increases the time HDL is able to prevent LDL oxidation.
IUBMB Life
; 64(2): 157-61, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22184096
5.
Paraoxonase-1 (PON-1) Arylesterase Activity Levels in Patients with Coronary Artery Disease: A Meta-Analysis.
Dis Markers
; 2022: 4264314, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35308142
6.
Cholesteryl-ester transfer protein enhances the ability of high-density lipoprotein to inhibit low-density lipoprotein oxidation.
IUBMB Life
; 63(9): 772-4, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21815241
7.
Immunohistochemical analysis of paraoxonases-1 and 3 in human atheromatous plaques.
Eur J Clin Invest
; 41(3): 308-14, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20964682
8.
Human tissue distribution of paraoxonases 1 and 2 mRNA.
IUBMB Life
; 62(6): 480-2, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20503442
9.
Anti-inflammatory properties of paraoxonase-1 in atherosclerosis.
Adv Exp Med Biol
; 660: 143-51, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20221877
10.
PON1 lactonase activity and its association with cardiovascular disease.
Clin Chim Acta
; 500: 47-53, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31626760
11.
High-density lipoprotein: why all the fuss?
Ann Clin Biochem
; 46(Pt 1): 5-7, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19015220
12.
Unexpectedly higher diazoxon hydrolysis by serum paraoxonase-1 in coronary heart disease.
Clin Biochem
; 65: 21-23, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30659791
13.
The epigenetic regulation of paraoxonase 1 (PON1) as an important enzyme in HDL function: The missing link between environmental and genetic regulation.
Clin Biochem
; 73: 1-10, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31351988
14.
PON1 concentration and high-density lipoprotein characteristics as cardiovascular biomarkers.
Arch Med Sci Atheroscler Dis
; 4: e47-e54, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31211270
15.
Comparison of the ability of paraoxonases 1 and 3 to attenuate the in vitro oxidation of low-density lipoprotein and reduce macrophage oxidative stress.
Free Radic Biol Med
; 45(6): 743-8, 2008 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18585453
16.
Defective metabolism of oxidized phospholipid by HDL from people with type 2 diabetes.
Diabetes
; 55(11): 3099-103, 2006 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17065348
17.
Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome.
Arterioscler Thromb Vasc Biol
; 26(7): 1545-50, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16627808
18.
Transcriptional regulation of human Paraoxonase 1 by nuclear receptors.
Chem Biol Interact
; 268: 77-84, 2017 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28223025
19.
Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
Circulation
; 107(12): 1640-6, 2003 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12668499
20.
Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
Circulation
; 110(20): 3259-69, 2004 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-15533870